Formulation Services
Our services allow us to create stable, effective drug delivery platforms. Our clients are able to achieve the optimum dosage form needed for faster commercialization.
Analytical Services
Demonstrating experience, efficiency and technical proficiency in the development and validation of analytical methodology, stability and storage support and GMP testing services.
Product Development
By utilizing our expertise in formulation development and technology transfer, Frontida challenges the industry standard. Offering immediate and modified release oral solid dose, liquids, and suspensions.
Contract Manufacturing
Our broad spectrum of manufacturing equipment and know-how provide innovative solutions for everything from traditional proprietary technologies, clinical trial materials, and commercial production goods.
Our 325,000ft² facility can manufacture up to 3 billion units per year. We supply oral pharmaceuticals to the U.S. market using our expertise in controlled release granules, serialization, blister and bottle packaging, powder packaging in stick packs, fluid bed operations, solvent processing, and DEA controlled substances.

Frontida is a contract development and manufacturing organization that works collaboratively with clients to bring products to the pharmaceutical market. We offer formulation, analytical method development and validation, process development, commercial manufacturing packaging and more.

We strive to improve the pharmaceutical and biotechnology industries by working with scientists who are dedicated to coming up with the best solutions for clients and patients. Our team is also extensively experienced in the development and manufacturing of oral dosage forms, including tablets and capsules.


Learn more about Frontida through the expertise
and insight from our management team.

Meet Our EVP of Business Development

Ron Connolly

Meet Our VP of Business Development

Uli Foley

Meet Our Director, Technical Services & Validation

Dominick Castaldo


Our fluid bed processing technology reduces production times by combining particle sizing and coating processes together, eliminating the need for extrusion and spheronization for high API-loaded drug particulates.


Our unique commercialized approach to adaptive formulation design provides the ability to combine multiple active ingredients and/or delivery rates in a single capsule using minitabs, beads, granules and liquids. Also appropriate for dose escalation studies.


    Team Member Perspectives